Catawba Research Partners With Elligo Health Research® to Expand Access and Simplify Clinical Research Participation

CHARLOTTE, N.C.–(BUSINESS WIRE)–Catawba Research, a leading global clinical research organization (CRO) that has established itself as a trusted partner in the development of new drugs and therapies, with a strong focus on delivering high-quality research solutions, announced a new partnership with Elligo Health Research, the largest healthcare-enabling research organization, that will expand access to clinical trials. All Catawba’s clinical studies will now be available through Elligo’s new Study Marketplace platform to drive participation and increase efficiencies for research sites and sponsors.


“At Catawba Research, we are focused on driving innovation in clinical research and delivering agile solutions across an evolving portfolio of therapeutic areas,” said Catawba CEO Andrew Silverman, Ph.D. “This fits our mission and partnering with Elligo helps create greater access to research as studies are being delivered to hundreds of experienced research and healthcare-first sites.”

Through Study Marketplace, Catawba’s studies are listed to more than 500 subscribing sites that can easily apply for those studies and track progress. Sites can quickly browse a curated portfolio of available studies that are the right fit for their site, apply for those of interest, track progress, and collaborate among team members. Ultimately, sites are receiving more effective site selection and patient recruitment, leading to accelerated timelines for trials.

“Study Marketplace was built to create more transparency and streamline the sales and site selection process between clinical trial sponsors, clinical research organizations (CROs), and sites,” said Elligo CEO John Potthoff, Ph.D. “At Elligo, we understand how challenging it is for sites to identify new study opportunities and manage the sales cycle. Moving Catawba trials from a manual process to Study Marketplace will allow sites to avoid jumping between countless systems and communication methods to manage trials, which means more time can be spent on trial execution and patient care.”

About Catawba Research

Catawba Research is a leading contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology and medical device industries. With a strong commitment to quality, innovation and client satisfaction, Catawba Research delivers comprehensive solutions to advance health care products from concept to market. For more information, please visit www.catawbaresearch.com.

Contacts

Lindsey Langemeier

SCORR Marketing

402-405-4269

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.